TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: plasma levels of sCD40L
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: prothrombin fragment F1+2 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Medical clearance rates for respirator use
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of the questionnaire in identifying work restrictions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bleeding scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: DBP (Diastolic Blood Pressure)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Functional recovery
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: pruritus AUC scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: worst pruritus score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of pruritus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Expression of CD 11b and CD 18
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Incidence of postoperative hyperthermia
Endpoint domain: Adverse events/effects
Primary endpoint: Sensory block to pinprick
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Motor block for arm, wrist, and hand movements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fasting plasma glucose (FPG) levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxygenation Index (OI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: median daily duration of SSC
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: perceptions of expected pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: self-efficacy to perform rehabilitation tasks
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: IKDC objective functional outcome scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneometer values
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Fitzpatrick wrinkle score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Proportion of responders to tetanus and pneumococcal vaccines
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Mild treatment-emergent adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Increasing walking activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: task performance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Straylight
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concern about development associated with neuro-developmental disorder
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Concern about mother-child relationship associated with emotional disturbances
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Completion rates at 1 year
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Mean weight losses at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time spent in physical activity
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Dose-proportional exposure of liraglutide
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Nocturia score improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Improved visualization of the Z-line
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Perceived benefit from ICU tour
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Mean access time for pEVAR vs cEVAR
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total access costs for pEVAR vs cEVAR
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Postoperative pain at day 1 and day 5
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Nocturnal voiding frequency improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Responder rate to treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Seroprotection against diphtheria, tetanus and Hib
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Response to acellular pertussis antigens
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Tolerance of DTaP‐Hib vaccine
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement of FMD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction of plasma concentrations of sICAM-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction of plasma concentrations of sVCAM-1
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fc epsilon RI expression
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Longitudinal strains by SDE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Radial strains by SDE
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Fecal bulk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Fecal butyrate concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: maximum K
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: UDVA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: HbA1c levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: ipsilateral events
Endpoint domain: Mortality/survival
Primary endpoint: Use of anticoagulant treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mean spherical aberration coefficient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean coma-like aberration coefficient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Corneal modulation transfer function
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: airway inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: ACQ score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: small airway parameter R5‐R20
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Postoperative pain profile
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: overall relief of symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: improvement of pressure symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: length of sick leave
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Complete ablation of HGD
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurrence of adenocarcinoma
Endpoint domain: Mortality/survival
Primary endpoint: Treatment-related adverse effects
Endpoint domain: Adverse events/effects
Primary endpoint: Complete healing rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ease-of-use score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Degree of pain during application
Endpoint domain: Adverse events/effects
Primary endpoint: Improvement on the MAL
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in distress
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Memory improvement
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: early rejection incidence
Endpoint domain: Adverse events/effects
Primary endpoint: BOS onset delay
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: APT (Averaged Power Time)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endothelial cell loss ratio
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anterior chamber flare counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Upper gastrointestinal bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: Lower gastrointestinal bleeding events
Endpoint domain: Adverse events/effects
Primary endpoint: body weight gain during treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of glucose intolerance requiring insulin
Endpoint domain: Adverse events/effects
Primary endpoint: incidence of cystic periventricular leukomalacia
Endpoint domain: Adverse events/effects
Primary endpoint: popliteal artery flow‐mediated dilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Recognition of postnatal problems
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Timely care-seeking
Endpoint domain: Life impact
Endpoint subdomain: Delivery of care
Primary endpoint: bimanual coordination
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: pinch force in the paretic hand
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: H. pylori infection cure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Reduction in neck pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FEV 1%
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: FEV 1/FVC levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: life quality (CAT)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Serum 25[OH]D concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Early NIV discontinuation rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mitral valve area (MVA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean diastolic gradient across the mitral valve
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Restenosis-free survival
Endpoint domain: Mortality/survival
Primary endpoint: z-scores of regional cerebral blood flow
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Plasma all‐E‐zeaxanthin concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Dose-normalized bioavailability of all‐E‐zeaxanthin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Terminal elimination half-life of all‐E‐zeaxanthin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: femoral neck bone mineral density change
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: bleaching effectiveness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: dental sensitivity
Endpoint domain: Adverse events/effects
Primary endpoint: Congestive heart failure requiring hospitalization
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Diabetic retinopathy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ophthalmological outcomes
Primary endpoint: BASDAI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BASFI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: BASMI scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: alcohol use outcomes
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Slow VT incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: blood flow of SVG conduits
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: memory quotient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: forward task score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: backward task score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain level due to mammographic compression
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Frequency of pulsatile release of oxytocin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: incidence of symptomatic antibiotic-treated UTIs
Endpoint domain: Adverse events/effects
Primary endpoint: number of additional antibiotic treatments
Endpoint domain: Adverse events/effects
Primary endpoint: GTT (Glucose Tolerance Test)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: knee flexion during the flight phase of the SL-DVJ
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: knee abduction after initial contact
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: peak knee-abduction excursion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Prediction accuracy of the PT-RO model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction of systolic and diastolic blood pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: family HRQL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: child HRQL
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Symptoms of depression scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Detection of endocervical cells
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of post-spinal anaesthesia shivering
Endpoint domain: Adverse events/effects
Primary endpoint: Grade IV shivering
Endpoint domain: Adverse events/effects
Primary endpoint: Requirement for meperidine to treat shivering
Endpoint domain: Adverse events/effects
Primary endpoint: percent change from baseline in 17β‐estradiol levels (E2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: 6‐minute‐walk distance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Normalization of DLPFC underactivation in ASD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Enhancement of PCC deactivation in ADHD
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Advanced stages of pubertal development
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: combined macrovascular and microvascular complication risk
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Blood pressure control rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Hospital admissions due to major drug-related problems (mDRPs)
Endpoint domain: Resource use
Endpoint subdomain: Hospital
Primary endpoint: Growth velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Correct regimen knowledge
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Respiration recovery time
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Strength gains
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: death or heart failure hospitalization
Endpoint domain: Mortality/survival
Primary endpoint: Bone height loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: time gain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: C acnes culture rate
Endpoint domain: Adverse events/effects
Primary endpoint: changes in PTSD symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Decline in Yale Brown Obsessive Compulsive Behavior Scale score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean total kcals purchased per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total fat purchased per week
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: 2-year mortality
Endpoint domain: Mortality/survival
Primary endpoint: myocardial infarction (MI) rates
Endpoint domain: Mortality/survival
Primary endpoint: target-vessel revascularization rates
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: LVEDD reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: LVESD reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: duration of off‐treatment response
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Gastric intramucosal acidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum interleukin-6 levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Leukocyte counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: median time before return to work or normal activity
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Prevention of PONV during the 4-h observation period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sedation scores at the end of the 4-h period
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: median between-groups difference in alignment of the mandibular labial segment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficiency in meeting chronic care health service needs
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Mitral Regurgitation (MR) at twelve-month follow-up
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of vessels in the maxillary sinus
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: success rate for DCCV
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean CK IU/L levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mean AST levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Reduction in serum glucose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in psychocognitive tests
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Need for implantable defibrillator
Endpoint domain: Adverse events/effects
Primary endpoint: Blood sugar
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Improvement in overbite
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: treatment engagement
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: treatment adherence
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Biochemical recurrence (BF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cancer specific survival (CSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 24-hour systolic blood pressure reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: 24-hour diastolic blood pressure reduction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Control rates defined as ABPM < or =130/80 mmHg
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: work-life balance
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Rectum sparing at medium-to-high dose range
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Urinary bladder shielding at medium dose
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Mean NTCP values for rectum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: self-efficacy to quit tobacco
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cement remnants
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Cement voids
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Marginal gaps
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: post-treatment recovery rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: effective rate 2 months after quitting treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes